Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 82

1.

A novel nitroxide is an effective brain redox imaging contrast agent and in vivo radioprotector.

Davis RM, Sowers AL, DeGraff W, Bernardo M, Thetford A, Krishna MC, Mitchell JB.

Free Radic Biol Med. 2011 Aug 1;51(3):780-90. doi: 10.1016/j.freeradbiomed.2011.05.019. Epub 2011 May 25.

2.

Probing the intracellular redox status of tumors with magnetic resonance imaging and redox-sensitive contrast agents.

Hyodo F, Matsumoto K, Matsumoto A, Mitchell JB, Krishna MC.

Cancer Res. 2006 Oct 15;66(20):9921-8.

3.

Evaluation of tempol radioprotection in a murine tumor model.

Hahn SM, Sullivan FJ, DeLuca AM, Krishna CM, Wersto N, Venzon D, Russo A, Mitchell JB.

Free Radic Biol Med. 1997;22(7):1211-6.

PMID:
9098095
4.

Evaluation of the hydroxylamine Tempol-H as an in vivo radioprotector.

Hahn SM, Krishna MC, DeLuca AM, Coffin D, Mitchell JB.

Free Radic Biol Med. 2000 Mar 15;28(6):953-8.

PMID:
10802227
5.

Differential radiation protection of salivary glands versus tumor by Tempol with accompanying tissue assessment of Tempol by magnetic resonance imaging.

Cotrim AP, Hyodo F, Matsumoto K, Sowers AL, Cook JA, Baum BJ, Krishna MC, Mitchell JB.

Clin Cancer Res. 2007 Aug 15;13(16):4928-33.

6.

Cell-penetrating nitroxides as molecular sensors for imaging of cancer in vivo, based on tissue redox activity.

Zhelev Z, Gadjeva V, Aoki I, Bakalova R, Saga T.

Mol Biosyst. 2012 Oct;8(10):2733-40. doi: 10.1039/c2mb25128k.

PMID:
22832934
7.

Brain contrasting ability of blood-brain-barrier-permeable nitroxyl contrast agents for magnetic resonance redox imaging.

Matsumoto K, Yamasaki T, Nakamura M, Ishikawa J, Ueno M, Nakanishi I, Sekita A, Ozawa Y, Kamada T, Aoki I, Yamada K.

Magn Reson Med. 2016 Sep;76(3):935-45. doi: 10.1002/mrm.25918. Epub 2015 Sep 28.

PMID:
26414669
8.

High-resolution mapping of tumor redox status by magnetic resonance imaging using nitroxides as redox-sensitive contrast agents.

Matsumoto K, Hyodo F, Matsumoto A, Koretsky AP, Sowers AL, Mitchell JB, Krishna MC.

Clin Cancer Res. 2006 Apr 15;12(8):2455-62.

9.

The stable nitroxide tempol facilitates salivary gland protection during head and neck irradiation in a mouse model.

Vitolo JM, Cotrim AP, Sowers AL, Russo A, Wellner RB, Pillemer SR, Mitchell JB, Baum BJ.

Clin Cancer Res. 2004 Mar 1;10(5):1807-12.

10.

Kinetics of tempol for prevention of xerostomia following head and neck irradiation in a mouse model.

Cotrim AP, Sowers AL, Lodde BM, Vitolo JM, Kingman A, Russo A, Mitchell JB, Baum BJ.

Clin Cancer Res. 2005 Oct 15;11(20):7564-8.

11.

A phase I study of topical Tempol for the prevention of alopecia induced by whole brain radiotherapy.

Metz JM, Smith D, Mick R, Lustig R, Mitchell J, Cherakuri M, Glatstein E, Hahn SM.

Clin Cancer Res. 2004 Oct 1;10(19):6411-7.

12.

Protection from lethal irradiation by the combination of stem cell factor and tempol.

Liebmann J, DeLuca AM, Epstein A, Steinberg SM, Morstyn G, Mitchell JB.

Radiat Res. 1994 Mar;137(3):400-4.

PMID:
7511822
13.

Small molecule GS-nitroxide ameliorates ionizing irradiation-induced delay in bone wound healing in a novel murine model.

Gokhale A, Rwigema JC, Epperly MW, Glowacki J, Wang H, Wipf P, Goff JP, Dixon T, Patrene K, Greenberger JS.

In Vivo. 2010 Jul-Aug;24(4):377-85.

14.

Tempol, a stable free radical, is a novel murine radiation protector.

Hahn SM, Tochner Z, Krishna CM, Glass J, Wilson L, Samuni A, Sprague M, Venzon D, Glatstein E, Mitchell JB, et al.

Cancer Res. 1992 Apr 1;52(7):1750-3.

15.

Potential use of nitroxides in radiation oncology.

Hahn SM, Krishna CM, Samuni A, DeGraff W, Cuscela DO, Johnstone P, Mitchell JB.

Cancer Res. 1994 Apr 1;54(7 Suppl):2006s-2010s. Review.

16.

Feasibility and assessment of non-invasive in vivo redox status using electron paramagnetic resonance imaging.

Yamada KI, Kuppusamy P, English S, Yoo J, Irie A, Subramanian S, Mitchell JB, Krishna MC.

Acta Radiol. 2002 Jul;43(4):433-40.

PMID:
12225490
18.

Factors influencing nitroxide reduction and cytotoxicity in vitro.

Samuni Y, Gamson J, Samuni A, Yamada K, Russo A, Krishna MC, Mitchell JB.

Antioxid Redox Signal. 2004 Jun;6(3):587-95.

PMID:
15130285
19.

Tissue redox activity as a sensing platform for imaging of cancer based on nitroxide redox cycle.

Zhelev Z, Aoki I, Gadjeva V, Nikolova B, Bakalova R, Saga T.

Eur J Cancer. 2013 Apr;49(6):1467-78. doi: 10.1016/j.ejca.2012.10.026. Epub 2012 Dec 20.

PMID:
23265713
20.

Protection from radiation-induced alopecia with topical application of nitroxides: fractionated studies.

Cuscela D, Coffin D, Lupton GP, Cook JA, Krishna MC, Bonner RF, Mitchell JB.

Cancer J Sci Am. 1996 Sep-Oct;2(5):273-8.

PMID:
9166544

Supplemental Content

Support Center